View in EDS

SLC26A2 as a key regulator and therapeutic target in hepatocellular carcinoma: evidence from pan-cancer and mechanistic studies.

Saved in:
Bibliographic Details
Title: SLC26A2 as a key regulator and therapeutic target in hepatocellular carcinoma: evidence from pan-cancer and mechanistic studies.
Authors: Wang R; The Second Clinical Medical School, Lanzhou University, Lanzhou, China.; Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou, China., Zhang X; The Second Clinical Medical School, Lanzhou University, Lanzhou, China.; Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou, China., Ren B; The Second Clinical Medical School, Lanzhou University, Lanzhou, China.; Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou, China., Zhou W; The Second Clinical Medical School, Lanzhou University, Lanzhou, China. zhouwc129@163.com.; Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou, China. zhouwc129@163.com.; Gansu Province Hepatobiliary Pancreatic Disease Precision Diagnosis and Treatment Engineering Research Center, Lanzhou, China. zhouwc129@163.com.
Source: Human genomics [Hum Genomics] 2026 May 08; Vol. 20 (1). Date of Electronic Publication: 2026 May 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101202210 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-7364 (Electronic) Linking ISSN: 14739542 NLM ISO Abbreviation: Hum Genomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1479-7364
DOI:10.1186/s40246-026-00970-7